Attachment research so far rarely has focused on attention deficit hyperactivity disorder (ADHD). This study is the first to examine the distribution of the attachment representation in mothers of children with ADHD. Considering results of clinical attachment studies we formulated the following hypothesis: the prevalence of maternal insecure and unresolved attachment representations increases with the degree of severity of children’s ADHD symptoms. Therefore it is highest in mothers of children with ADHD who are treated clinically (group A). It is expressed less strongly in mothers of children with ADHD symptoms without need for clinical treatment (group B). In a control group of mothers whose children have no ADHD diagnosis (group C), there is the lowest prevalence of insecure and disorganized attachment representations. Within a period of 6 months from a total of 72 recruited children and their mothers screened according to participation criteria (e.g. ICD-10: F90 Hyperkinetic disorders), 13 mothers could be assigned to group A, 19 mothers to group B, and 19 mothers to group C. The attachment representation was assessed using the Adult Attachment Projective. To test the sequence order hypothesis we used the Jonckheere-Terpstra test (u = 3.78; p < 0.001). The increasing clinical conspicuity in the groups obviously is connected to a reduced prevalence of the autonomous attachment representations as well as to an increase of the insecure and unresolved attachment representations of the mothers. We interpret this result with respect to the treatment of children with ADHD as a vote for considering the family context as well as early intervention strategies which aim at the improvement of the quality of maternal sensitivity.

Keywords:
Attachment representation, Attention deficit hyperactivity disorder, Adult Attachment Projective
This content is only available via PDF.
© 2009 S. Karger AG, Basel
2009
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.